CSCI
Price
$3.96
Change
-$0.00 (-0.00%)
Updated
Jul 25 closing price
Capitalization
12.28M
JANX
Price
$25.96
Change
-$0.01 (-0.04%)
Updated
Jul 25 closing price
Capitalization
1.54B
17 days until earnings call
Interact to see
Advertisement

CSCI vs JANX

Header iconCSCI vs JANX Comparison
Open Charts CSCI vs JANXBanner chart's image
COSCIENS Biopharma
Price$3.96
Change-$0.00 (-0.00%)
Volume$4.53K
Capitalization12.28M
Janux Therapeutics
Price$25.96
Change-$0.01 (-0.04%)
Volume$1.32M
Capitalization1.54B
CSCI vs JANX Comparison Chart in %
Loading...
CSCI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CSCI vs. JANX commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSCI is a StrongBuy and JANX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (CSCI: $3.90 vs. JANX: $25.96)
Brand notoriety: CSCI and JANX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CSCI: 30% vs. JANX: 174%
Market capitalization -- CSCI: $12.28M vs. JANX: $1.54B
CSCI [@Biotechnology] is valued at $12.28M. JANX’s [@Biotechnology] market capitalization is $1.54B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CSCI’s FA Score shows that 0 FA rating(s) are green whileJANX’s FA Score has 0 green FA rating(s).

  • CSCI’s FA Score: 0 green, 5 red.
  • JANX’s FA Score: 0 green, 5 red.
According to our system of comparison, CSCI is a better buy in the long-term than JANX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CSCI’s TA Score shows that 6 TA indicator(s) are bullish while JANX’s TA Score has 6 bullish TA indicator(s).

  • CSCI’s TA Score: 6 bullish, 4 bearish.
  • JANX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both CSCI and JANX are a good buy in the short-term.

Price Growth

CSCI (@Biotechnology) experienced а -9.93% price change this week, while JANX (@Biotechnology) price change was -1.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

CSCI is expected to report earnings on May 13, 2025.

JANX is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JANX($1.54B) has a higher market cap than CSCI($12.3M). CSCI YTD gains are higher at: 40.794 vs. JANX (-51.513). CSCI has higher annual earnings (EBITDA): -15.36M vs. JANX (-111.54M). JANX has more cash in the bank: 1.01B vs. CSCI (13.8M). CSCI has less debt than JANX: CSCI (2.23M) vs JANX (22.6M). JANX (9.34M) and CSCI (9.03M) have equivalent revenues.
CSCIJANXCSCI / JANX
Capitalization12.3M1.54B1%
EBITDA-15.36M-111.54M14%
Gain YTD40.794-51.513-79%
P/E RatioN/AN/A-
Revenue9.03M9.34M97%
Total Cash13.8M1.01B1%
Total Debt2.23M22.6M10%
FUNDAMENTALS RATINGS
CSCI: Fundamental Ratings
CSCI
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
69
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
96
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CSCIJANX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 9 days ago
74%
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
CSCI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PEIQX41.88N/A
N/A
Principal Equity Income R5
FGHMX122.39N/A
N/A
Fidelity Advisor Communication ServicesC
NREEX14.00N/A
N/A
Neuberger Berman Real Estate E
VIOAX9.82N/A
N/A
VELA Income Opportunities A
PMICX10.93N/A
N/A
Putnam Multi-Asset Income C

CSCI and

Correlation & Price change

A.I.dvisor tells us that CSCI and SLDB have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CSCI and SLDB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CSCI
1D Price
Change %
CSCI100%
-1.52%
SLDB - CSCI
30%
Poorly correlated
+4.79%
SNGX - CSCI
30%
Poorly correlated
-5.04%
JANX - CSCI
29%
Poorly correlated
-0.04%
ARDX - CSCI
28%
Poorly correlated
-1.61%
FATE - CSCI
27%
Poorly correlated
-0.80%
More

JANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, JANX has been loosely correlated with SKYE. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if JANX jumps, then SKYE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JANX
1D Price
Change %
JANX100%
-0.04%
SKYE - JANX
41%
Loosely correlated
-2.49%
CRNX - JANX
39%
Loosely correlated
+1.91%
IDYA - JANX
38%
Loosely correlated
-1.33%
SYRE - JANX
37%
Loosely correlated
+1.08%
TERN - JANX
37%
Loosely correlated
-0.17%
More